Sitemap
March 29, 2020 Articles
Filter by Available Specialty
- Apixaban noninferior to dalteparin for cancer-related VTE treatment
- FDA approves wrist replacement implant designed by HSS surgeon
- ISCHEMIA results consistent across subgroups; invasive strategy may be harmful in advanced CKD
- Low-risk TAVR for bicuspid valves yields few adverse events
- New insights on low-risk TAVR vs. surgery: PARTNER 3 at 2 years
- Oral anticoagulation alone reduces bleeding after TAVR vs. dual therapy
- Renal denervation safely reduces BP in absence of antihypertensive medications
- Sodium nitrite confers no survival benefit in out-of-hospital cardiac arrest
- UCLA, UT Southwestern cancer centers join National Comprehensive Cancer Network
- UK TAVI: In real-world population, TAVR noninferior to surgery at 1 year
- VIDEO: Impact of coronavirus on a private practice in Ohio, part 4